Full-Time

Principal Scientist

Analytical Chemistry

Posted on 11/4/2024

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

AI & Machine Learning
Biotechnology

Compensation Overview

$178k - $194.8kAnnually

+ Bonus + Equity Compensation

Senior, Expert

Hayward, CA, USA

Positions will move to Millbrae, CA starting April 2025.

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Postdoc fellowship plus 7 years or a PhD plus a minimum of 10 years of relevant experience or a Master’s degree with 12 years of relevant experience in process chemistry and drug substance development.
  • CMC analytical knowledge and experience with various dosage forms (solid oral, injectable, etc.) is required.
  • Proven track record of successfully providing analytical support for FIH formulation development and regulatory submissions.
  • Strong understanding of FDA and EMA regulatory requirements and quality systems.
  • Excellent communication, leadership, and problem-solving skills with hands-on knowledge of analytical methods and quality control processes.
  • Ability to work in a fast-paced, dynamic environment and manage multiple priorities.
  • Strong analytical and problem-solving skills.
  • Excellent interpersonal and communication skills, capable of leading and motivating teams.
  • Commitment to maintaining high quality standards.
Responsibilities
  • Serve as the project lead in the development, method transfer, and validation of analytical methods from early clinical stage through commercial stages.
  • Monitor project progress and ensure milestones are met.
  • Oversee analytical projects and manage timelines at CROs/CDMOs.
  • Collaborate with cross-functional teams including Research Project Teams, Regulatory Affairs, Quality Assurance, Manufacturing, Supply Chain and Clinical Operations, as well as CMC-drug substance and drug product formulation teams, to ensure seamless product development to commercial.
  • Develop and execute analytical project plans, timelines, and project strategy.
  • Ensure all CMC activities comply with regulatory requirements (FDA, EMA, etc.).
  • Prepare and review CMC sections of regulatory submissions, including INDs, NDAs, and BLAs.
  • Interact with regulatory agencies to address CMC-related queries and provide necessary documentation.
  • Implement online process analytical techniques to enhance control strategies.
  • Provide analytical technical expertise, including laboratory responsibilities, to support drug product formulation, drug substance synthesis, and manufacturing.
  • Stay updated on industry trends, technological advancements, and the latest developments in analytical chemistry and regulatory trends.
  • Mentor and develop junior staff members.

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company utilizes advanced technologies to study biological systems, aiming to identify new targets for drug development by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that improve and extend life. A key feature of their approach is a proprietary single-molecule tracking (SMT) platform that visualizes protein motion in living cells, enabling them to analyze molecular interactions with high precision. Eikon Therapeutics aims to serve patients with serious diseases by developing effective treatments and generates revenue through the commercialization of these therapies.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

7%

1 year growth

11%

2 year growth

59%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's SMT technology aligns with the trend of high-resolution imaging in drug discovery.
  • The acquisition of TLR7/8 agonist assets positions Eikon in the growing immuno-oncology field.
  • Experienced industry veterans enhance Eikon's ability to navigate complex regulatory environments.

What critics are saying

  • Rapid expansion may strain resources and impact operational efficiency.
  • Competitive pressures exist in the PARP1 selective inhibitors market.
  • Reliance on SMT technology poses a risk if superior technologies emerge.

What makes Eikon Therapeutics unique

  • Eikon's SMT platform offers real-time, molecular-resolution imaging of protein movement in living cells.
  • The company integrates AI and advanced automation for large-scale molecular interaction analysis.
  • Eikon's diverse team combines expertise in science, engineering, and clinical development.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE